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WHAT THIS PAPER ADDS
 In those centres which already undertake expedited CEA in the majority of their patients and who manage to do so without
encountering recurrent symptoms before surgery, clearly there is little that needs to be changed. However, this situation probably
does not apply to themajority of vascular centreswho currently struggle to see large numbers of patients quickly and then get those
with signiﬁcant ipsilateral stenoses processed and submitted to surgery within days of onset of symptoms. In the latter type of unit,
the data from this study would suggest that if there is any likelihood of delays entering the patient pathway (eg no spaces on
existing elective theatre lists or weekend approaching), consideration might be given to considering emergency CEA in the small
cohort of recently symptomatic patients who have evidence of a low GSM (<25), in association with a juxta-luminal black area
exceeding 6mm2 on computerised plaque analysis.a r t i c l e i n f o
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Objectives: The aim of the current study was to determine whether computerised ultrasound plaque
analysis could identify features predictive of an increased risk of early recurrent events after symptom
onset.
Methods: Between August 2008 and December 2010, 158 consecutive symptomatic patients undergoing
carotid endarterectomy (CEA) had their plaques harvested at CEA and then independently scored for
markers of histological plaque instability. Duplex ultrasound images recorded prior to CEA were inde-
pendently assessed using the Iconsoft software.
Results: One hundred and ﬁfty eight recently symptomatic patients underwent CEA with 118 (75%)
undergoing their operation within 14 days of their most recent clinical event. Twenty (12.7%) suffered
a recurrent cerebral ischaemic event following admission to the vascular unit and before undergoing
CEA. Using multivariate stepwise analysis; lipid core (OR 4.00, 95% CI 1.07 to 14.83, P ¼ 0.042) and a low
GSM (OR 6.21, 95% CI 1.86 to 20.4, P ¼ 0.003) were independently associated with recurrent cerebro-
vascular events.
Conclusion: Within a cohort of patients presenting with recent onset cerebral ischaemic events under-
going CEA, the plaques of patients with recurrent events following admission to hospital had evidence
a large lipid core and a low GSM.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.x: þ44 116 252 3179.
ciety for Vascular Surgery. PublisheIntroduction
Over the last ﬁve years, there has been a drive towards per-
forming expedited carotid endarterectomy (CEA) within the
hyperacute period after onset of symptoms. This is because the risk
of recurrent stroke is highest within the ﬁrst two weeks after onsetd by Elsevier Ltd. All rights reserved.
Figure 1. Image normalisation using a sample of ‘blood’ free from noise and a sample
from the inner two-fourths of the brightest part of the adventitia adjacent to the
plaque.
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period reduce the cumulative beneﬁt conferred by surgery. In
a recent study, it was shown that it was possible to reconﬁgure the
entire treatment pathway for TIA/minor stroke patients so that they
could undergo expedited surgery without incurring a signiﬁcant
increase in the procedural risk.2 The main changes in practice
(compared to previous) were that patients were rapidly triaged for
clinic attendance through their ABCD2 score, Aspirin and Statin
therapy was physically started in the TIA Clinic (as recommended
by the EXPRESS Study3) and patients with an ipsilateral 50e99%
stenosis were transferred directly from the TIA Clinic to the
Vascular Surgery Unit for urgent surgery.2
One consequence of this move towards expedited surgery was
that the Unit encountered a greater proportion of patients suffering
recurrent cerebral ischaemic events following admission and
before undergoing surgery, suggesting that they had highly
unstable plaques. This was despite having started antiplatelet and
statin therapy before transfer. Previous studies have identiﬁed that
ultrasound analysis can detect differences in plaque morphology
and symptomatic status.4,5 The aim of the current study was to
determine whether the histology or ultrasonographic features in
these patients somehow differed from other ‘recently symptomatic
patients’ awaiting surgery.
Methods
The current study was authorised by the Leicestershire, North-
amptonshire and Rutland Ethics Committee and patients were
entered after giving informed consent.
Patient selection
All recently symptomatic patients with a >50% NASCET extra-
cranial carotid artery stenosis who were admitted to the Leicester
Vascular Surgery unit for CEAwere considered for inclusion. All had
been referred via a Stroke Physician (most via the rapid access TIA
Clinic which was established in October 2008),2 although a relative
minority were referred sometime after the index event. This was
usually because the patient presented late to the referring Stroke
Physician. In the TIA Clinic, the consultant Stroke Physician took
responsibility for optimising risk factors. Each patient was
commencedonstatin therapy (Simvastatin40mgdaily), antiplatelet
therapy (300 mg loading dose of Aspirin plus 200 mg Dipyridamole
followed by Aspirin 75 mg daily, in addition 75 mg clopidogrel was
given the night before surgery) and antihypertensive therapy as
appropriate. Carotid surgery was performed as soon as possible
following admission, provided there were no contra-indications. If
a patient suffered a recurrent ischaemic event, every effort was
made to perform CEA as soon as possible thereafter.
Data collection
Pre-operative clinical data were recorded by a single investi-
gator (MS) through face to face questioning of patients and after
review of medical notes and in-patient investigations. Demo-
graphic data recorded included age, sex, vascular risk factors
(hypertension, hyperlipidaemia, diabetes mellitus and smoking),
pre-operative medication, time from index event and most recent
event (including recurrent events after admission) to imaging and
surgery.
Duplex imaging
Carotid Duplex Ultrasound imaging was performed in the Rapid
Access TIA clinic and then again following admission to theVascular Unit in accordance with HTA guidelines.6 All Duplex
examinations were undertaken by experienced ultrasonographers
and stenosis severity was measured using consensus criteria
consistent with the NASCET mode of measurement.7 The second
duplex image taken after admission to the Vascular Surgery Unit
was used for analysis. Enhanced, normalised and non-normalised
images were used for blinded off-line analysis by a single investi-
gator (AN).Image normalization and measurements of GSM and JBA (see
Figs. 1e3)
The “Plaque Texture Analysis software” (Iconsoft International
Ltd, Greenford, London, UK), is a dedicated research software
package and has ﬁve modules: (1) image normalization; (2)
measurements (distances such as IMT, plaque thickness and areas);
(3) pixel-density standardization (this is essential for texture
features that are pixel-density-dependent); (4) imagecrop (out-
lining the plaque and saving it as a separate ﬁle); and (5) feature
extraction (including GSM). Normalization was performed using
the “image normalization” module. First, a sample of “blood” was
selected from the vessel lumen avoiding areas of “noise”. Next,
using the zoom facility the brightest part of adventitia adjacent to
the plaquewasmagniﬁed at least twice and themiddle two-fourths
were selected (Fig. 1). Pressing the “features extraction” button in
this window or using the “feature extraction” module produced
Figure 2. ‘Unstable’ plaque detected on ultrasound analysis. Juxta-luminal black area outlined in white. DWAs are bright red areas within the black lumen.
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including GSM and saved in a database that could be opened by
Microsoft Ofﬁce Excel (Microsoft Inc., Redmond, Wash).
Parameters measured using the Iconsoft Plaque Texture Analysis
Software included 1. Juxta-Luminal Black Area; 2. Discrete White
Areas; 3. Type of Plaque; 4. Plaque area and percentage area and 5.
GSM (Table 1).
The deﬁnitions and reproducibility of texture features used in
this study are given below.
Grey scale median (GSM)
This was the median of the grey values of all the pixels in the
plaque image.811 In a reproducibility study of 35 plaques
measured by two observers, the inter-observer mean difference of
GSM was 3.6, the within-subject standard deviation was 13.6 and
the intra-class correlation coefﬁcient was 0.93.8Table 1
Ultrasound scoring based on Iconsoft Plaque Texture Analysis software.
Ultrasound feature ‘Stable’ ‘Unstable’
GSM >25 <25
Juxta-luminal black area <6 mm2 >6 mm2
Discrete white areas No Yes
Plaque type 3 & 4 1 & 2
Plaque area <80 mm2 >80 mm2Plaque type
Plaque types were scored automatically by the software
according to a modiﬁed Geroulakos classiﬁcation.12,13
Type 1. Uniformly echolucent (black): <15% of the pixels in the
plaque areawere occupied by pixels with grey scale values> 25.
Type 2. Mainly echolucent: pixels with grey scale values > 25
occupy 15e50% of the plaque area.
Type 3. Mainly echogenic: pixels with grey scale values > 25
occupy 50e85% of the plaque area.
Type 4 or 5. Uniformly echogenic: pixels with grey scale
values > 25 occupy >85% of the plaque area.
A reproducibility study involving 1062 plaques classiﬁed visu-
ally by one observer after image normalization and automatically
by the software had a kappa statistic of 0.61 (P < 0.001). Because of
the low event rate in plaque types 4 and 5 as previously demon-
strated11 and because the software cannot distinguish between
them, these plaque types have been grouped together.
Plaque area
This was calculated by the software using the distance scale on
the side of the image frame for calibration and the plaque area
outlined by the operator. It was expressed in mm2.8,14 In a repro-
ducibility study involving 50 plaques the inter-observer intra-class
correlation coefﬁcient was 0.73. A threshold of 80 mm2 was used to
Figure 3. ‘Stable’ Plaque features detected on ultrasound analysis. Juxta-luminal black area outlined in white. DWAs are bright red areas within the black lumen.
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ment of symptoms.14
Discrete white areas (DWA) (Figs. 2 and 3)
The presence of DWA deﬁned as areas with pixels having grey
scale values > 124 (coloured red by the software for easy visual
identiﬁcation) not producing acoustic shadowing in plaque types
1e3. DWAswhich are non calciﬁed white areas (absence of acoustic
shadow) within black areas have been previously associated with
development of symptoms.15
Juxta-luminal black areas (Figs. 2 and 3)
Juxta-luminal black area without visible echogenic cap (JBA).
The largest juxta-luminal black area of the contoured image (i.e.
area with pixels having a grey scale less than 25) without a visible
echogenic cap (i.e. pixels with grey-scale value equal or higher than
25) was outlined by the mouse and expressed as mm2. This was
automatically calculated by the software using the on-screen mm
scale from each ultrasonic image. The larger valuewas used in cases
where there were two plaque components with black areas. A JBA
>6 mm2 was deﬁned as being large.
TCD detection of spontaneous embolisation
A 30 min period of TCD monitoring was performed using
a commercially available TCD machine (Sonara TCD System fromViasys Healthcare) with the 2-MHz head probe held in place by an
external ﬁxation device. Insonation of the ipsilateral MCA was
achieved via the temporal acoustic window at a depth of
50e60 mm using a 2-MHz pulsed Doppler transducer. The sample
volume (generally 8e13 mm), power and gain were adjusted to
ensure an optimal embolic signal to background signal relationship.
Each embolic signal was recorded and categorised using the
Consensus Committee Criteria16 to differentiate between true
emboli and other high intensity transient signals (HITS), including
artefacts.
Carotid endarterectomy
Carotid surgery was performed under general anaesthesia with
routine patching, routine shunting, systemic heparinisation
(unfractionated) and distal intimal tacking sutures.17 Endarterec-
tomy was performed via a linear arteriotomy and the plaque
removed with the minimum of trauma possible.
Recurrent clinical event
A recurrent cerebral ischaemic event was deﬁned as any
further episode of stroke, TIA or amaurosis fugax between the
time of admission to the Vascular Surgery Unit and undergoing
surgery. Any patient suffering a recurrent event underwent
a repeat CT scan, extra-cranial Duplex ultrasound examination
Table 2
Semi-quantitative scoring system for histological.14
Histological Feature Grade 0 Grade 1 Grade 2 Grade 3
Haemorrhage No haemorrhage Small haemorrhage Large haemorrhage e
Thrombus No thrombus Small thrombus Large thrombus e
Lipid core No lipid core Small lipid core Large lipid core e
Fibrous tissue Very little ﬁbrous tissue Approx 50% ﬁbrous tissue Predominantly ﬁbrous tissue e
Chronic plaque inﬂammation None Occasional cells or one group >50 2e5 groups >50 >5 groups >50 or 1 group >500
Chronic cap inﬂammation None <10 cells in cap 10e50 cells in cap >50 cells in cap
Acute plaque inﬂammation None Occasional cells or one group >50 2e5 groups >50 >5 groups >50 or 1 group >500
Acute Cap Inﬂammation None <10 cells in cap 10e50 cells in cap >50 cells in cap
Foam cells None <50 cells >50 cells e
Neovascularity None <10/section >10/section e
Cap rupture Intact Probably intact Probably ruptured Deﬁnitely ruptured
Table 3
Demographics for symptomatic patients presenting with/without recurrent cerebral
ischaemic events after admission to the Vascular Surgery Unit.
patient demographics No recurrent
event (n ¼ 138)
Recurrent
event (n ¼ 20)
P value
Male 97 (70%) 15 (75%) 0.6
Female 41 (30%) 5 (25%) 0.6
Age (median) 73 (37e94) 70 (52e87) 0.9
Hypertension 94 (68%) 14 (70%) 0.8
Hypercholesterolaemia 109 (79%) 18 (90%) 0.5
Diabetes mellitus 23 (30%) 2 (10%) 0.4
Ischaemic heart disease 21 (27.6%) 8 (40%) 0.1
Ex/current smoker 101 (73%) 14 (70%) 1
On Antiplatelet therapy
following admission
105 (100%) 20 (100%) 1
Antiplatelet therapy
pre-admission
132 (96%) 20 (100%) 0.6
On statin therapy
following admission
138 (100%) 20 (100%) 1
On statin therapy pre-admission 132 (96%) 20 (100%) 0.6
Median time from index event
to undergoing surgery
14 days (2e180) 11 days (3e35) 0.08
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embolisation.
Histopathology
Plaques harvested during CEA were divided longitudinally and
randomly one half ﬁxed immediately in formalin for 24 h and
then parafﬁn embedded. A 5um transverse section was taken
from the parafﬁn block and stained using haematoxylin and
eosin.
Histological specimens were analysed by two independent
Histopathologists (KW, DM) who were blinded to the clinical and
ultrasound ﬁndings.
Histological features
For each plaque, a semi-quantitative 3 or 4 point score (Table 2)
was assigned to show the presence and/or amount of features of
plaque instability based on the AHA histological classiﬁcation of
advanced atherosclerotic lesions18 and a well validated previously
published scoring system.19 Features analysed included; intra-
plaque haemorrhage, haemosiderin deposition, surface thrombus,
lipid core size, nodular calciﬁcation, proportion of ﬁbrous tissue,
acute and chronic plaque inﬂammatory inﬁltrate, acute and chronic
cap inﬂammatory inﬁltrate, neovascularity, amount of foam cells,
and evidence of cap rupture. Intra-plaque haemorrhage was
deﬁned as evidence of erythrocytes within the plaque causing
disruption of plaque architecture as deﬁned by Bassiouny.20 Surface
thrombus was deﬁned as the presence of an organised collection of
ﬁbrin and red blood cells in the lumen as demonstrated by Lam-
mie.21 Lipid core was deﬁned as an area of amorphous material
containing cholesterol clefts. Rupture was deﬁned as a clear
communication between lipid core and lumen with a break in the
ﬁbrous cap. Calciﬁcation was identiﬁed through evidence of
nodular deposits.
Statistical analysis
t-Test and c2 was used to compare baseline characteristics
between patients with recurrent events and those without. A
stepwise multivariate analysis was performed to identify inde-
pendent associations between patients with recurrent events and
histological and ultrasound features identiﬁed above. Statistical
analysis was performed using SPSS (v16).
Results
Between August 2008 and December 2010 One hundred and
ﬁfty eight patients were included in the study and all had complete
histological data. However, 13 ultrasound images from the earlypart of the study were found to be unsuitable for computerised
analysis and 12 sets of images were lost during transfer from the
mobile scanner to the vascular studies unit. This left 133 duplex
ultrasound images for direct comparison against histological
features.
Seventy ﬁve patients (47%) underwent surgery within seven
days of suffering their most recent clinical event, 43 (27%) within
8e14 days,17 (11%) within 15e28 days, while>29 days had elapsed
in 23 patients (14%). This, therefore, provided a broad spectrum of
patients with regard to delays to surgery ranging from the hyper-
acute period (<14 days, n¼ 118), intermediate (15e28 days, n¼ 17)
and late (>29 days, n ¼ 23). The median delay from admission to
imaging and undergoing surgery in patients with recurrent events
was 1 day (0e12) and was 1 day (0e4) in those with no recurrent
events prior to surgery (P ¼ ns).
Twenty patients suffered recurrent cerebral ischaemic events
after admission to the vascular unit; stroke n ¼ 1 (5%); TIA n ¼ 16
(80%) and Amaurosis Fugax n ¼ 3 (15%). All recurrent events were
the same as the presenting event. Baseline patient characteristics
are listed in Table 3.
Table 4 shows the comparison between duplex imaging features
in patients with recurrent symptoms and those without symptoms.
A plaque area >80 mm2 was more common in patients with
recurrent symptoms, but this did not reach statistical signiﬁcance.
Discrete white areas were found equally in both groups. Univariate
analysis of ultrasound based criteria showed type 1/2 plaque (OR
5.79 95% CI 1.8e18.5; P ¼ 0.005), an echolucent plaque (GSM < 25)
(OR 4.68, 95% CI 1.58 to 13.8, P ¼ 0.03) and positive juxta-luminal
black area (OR 3.56, 95% CI 1.1 to 11.4, P ¼ 0.05) were signiﬁcantly
Table 4
Ultrasound Plaque features present in plaques from patients with recurrent events Vs non-recurrent events.
Ultrasound feature No recurrent event n ¼ 115 (86.4%) Recurrent event n ¼ 18 (13.6%) P value
GSM (<25) 25 21.7% 9 50% 0.03
Juxta-luminal black area (>6 mm2) 33 37% 11 61.1% 0.049
Discrete white areas (Yes) 66 57.3% 10 55.5% 1
Plaque type (1e2) 23 25.8% 10 55.5% 0.005
Plaque area (>80 mm2) 43 37.3% 8 44.4% 0.6
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those patients without recurrent events.
Table 5 shows the comparison between histological features in
patients with recurrent symptoms and those with no recurrent
symptoms. Features including any haemorrhage, any thrombus,
chronic plaque inﬂammation, chronic cap inﬂammation, acute
plaque inﬂammation and cap rupture were more prevalent in the
recurrent symptomatic group, but did not reach statistical signiﬁ-
cance. Interestingly, predominantly ﬁbrous tissue, acute cap
inﬂammation and marked vascularity were more common in the
non-recurrent symptomatic group. Univariate analysis of histolog-
ical features showed that a large lipid core was signiﬁcantly more
common in patients with recurrent events than the cohort without
recurrent events (OR 10.8, 95% CI 1.4 to 83, P ¼ 0.004).
Table 6 shows that patients with spontaneous embolisation
during 30min pre-operative Transcranial Doppler monitoring were
signiﬁcantly more likely to have recurrent events than those
patients without evidence of spontaneous embolisation (OR 3.87,
95% CI 1.39 to 10.7, P ¼ 0.007).
In a multivariate stepwise analysis of histological features,
ultrasound features and TCD diagnosed embolisation only a large
lipid core (OR 4.00, 95% CI 1.07 to 14.83, P ¼ 0.042) and low GSM
(OR 6.21, 95% CI 1.86 to 20.4, P ¼ 0.003) were independently
predictive of an increased risk of recurrent events. Interestingly the
presence of spontaneous embolisation during 30min pre-operative
TCD monitoring was not found to have a signiﬁcant association
after multiple regression analysis.Discussion
Previous studies have correlated plaque histology with delays
from onset of symptoms to surgery,22 but few have included
sufﬁcient numbers of patients in the hyperacute period after onset
of symptoms (<7 days), while none have evaluated histological and
ultrasonographic features in those suffering recurrent symptoms
between admission and undergoing surgery.
Recent meta-analyses have suggested that the risk of recurrent
stroke is highest in the ﬁrst few days after onset of symptoms2,23Table 5
Histological features present in plaques from patients with recurrent events Vs non-
recurrent.
Histological feature No recurrent event
n ¼ 138 (87.4%)
Recurrent event
n ¼ 20 (12.6%)
P value
Any haemorrhage 92 66.6% 16 80% 0.3
Any thrombus 47 34% 9 45% 0.45
Large lipid core 89 64.4% 19 95% 0.002
Predominant ﬁbrous tissue 20 14.4% 0 0% 0.07
Chronic plaque inﬂammation 118 85.5% 19 95% 0.47
Chronic cap inﬂammation 58 42% 11 55% 0.33
Acute plaque inﬂammation 9 6.5% 2 10% 0.63
Acute cap inﬂammation 9 6.5% 1 5% 1
Many foam cells 63 45.6% 8 40% 0.81
Marked vascularity 115 83.3% 16 80% 0.75
Cap rupture 66 47.8% 11 55% 0.63and much higher than was previously thought.24,25 These data
refer to ‘all TIA patients’, but Ois et al. have suggested that the early
risk of recurrent stroke may be even higher in patients with
signiﬁcant ipsilateral 50e99% carotid stenoses.26 In the current
series, 75% of patients underwent surgery within 14 days of their
most recent event and 13% of patients suffered recurrent ischaemic
events before they could undergo surgery, suggesting that the early
period after onset of symptoms remains a high risk time. Inter-
estingly, all had been started on statin and antiplatelet therapy in
the TIA Clinic and the median delay from admission to CEA in
patients with recurrent symptoms was 1 day (0e12), while the
delay for those without recurrent symptoms was also 1 day (0e4)
(P¼ ns). All but one of the recurrent events were TIAs or Amaurosis
Fugax and 70% had evidence of spontaneous embolisation
compared to 38% of those with no recurrent symptoms.
If we assume that the presence of recurrent symptoms following
admission (despite antiplatelet and statin therapy) is a marker of
a highly unstable plaque, it is interesting to observe the histological
and ultrasonographic correlates, both of which were scored inde-
pendently without any knowledge of clinical demographics. On
univariate analysis (Table 5), the plaques of patients with recurrent
symptoms after admission showed that the only statistically
signiﬁcant histological feature was the presence of a large lipid core
(OR 10.8, 95% CI 1.4 to 83, P ¼ 0.004). The following features were
not associated with an increased risk of recurrent symptoms; any
haemorrhage, any thrombus, predominant ﬁbrous tissue, chronic
plaque inﬂammation, chronic cap inﬂammation, acute plaque
inﬂammation, acute cap inﬂammation, many foam cells, marked
vascularity and cap rupture.
Similarly, the plaques of patients with recurrent symptoms had
a signiﬁcantly higher prevalence of echolucent plaque (GSM < 25)
(OR 4.68, 95% CI 1.58 to 13.8, P ¼ 0.03), large juxta-luminal black
areas (>6mm2) (OR 3.56, 95% CI 1.1 to 11.4, P¼ 0.05) and type 1 or 2
Plaques (OR 5.79 95% CI 1.8e18.5; P ¼ 0.005). Interestingly, the
presence of discrete white areas and large plaque area (>80 mm2)
were not associated with an increased risk of recurrent symptoms
(Table 4).
Following multivariate analysis, the following key histological
and ultrasonographic features were associated with an increased
risk of suffering recurrent cerebral ischaemic events; a large lipid
core (OR 4.00, 95% CI 1.07 to 14.83, P ¼ 0.042) and low GSM (OR
6.21, 95% CI 1.86 to 20.4, P ¼ 0.003).
So how might these data inﬂuence future clinical practice? It is
all very well knowing that a large lipid core correlates with an
increased risk of recurrent events, but this histological feature is of
limited predictive value to the surgeonwho is trying to decide upon
the best management strategy. However, because Duplex ultra-
sound is so versatile and readily accessible, the positive correlation
with TCD embolisation and computerised plaque features might
facilitate changes in practice.
In those centres who already undertake expedited CEA in the
majority of their patients and who manage to do so without
encountering recurrent symptoms before surgery, clearly there is
little that needs to be changed. However, this situation probably
does not apply to the majority of vascular centres who currently
Table 6
TCD data of spontaneous embolisation in patients with recurrent events versus no recurrent events.
Transcranial Doppler data No recurrent eventa (n ¼ 125) Recurrent event (n ¼ 20) P value
Spontaneous embolisation detected 47 37.6% 14 70% 0.007
a No window available in 13 patients.
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with signiﬁcant ipsilateral stenoses processed and submitted to
surgery within days of onset of symptoms. In the latter type of unit,
the data from this study would suggest that if there is any likeli-
hood of delays entering the patient pathway (i.e. no spaces on
existing elective theatre lists or weekend approaching), consider-
ation might be given to performing an emergency CEA in the small
cohort of recently symptomatic patients who have evidence of
a low GSM (<25), in association with either a juxta-luminal black
area exceeding 6 mm2 on computerised plaque analysis or TCD
evidence of spontaneous embolisation.
Few studies have evaluated histological and ultrasonographic
features in such a large cohort of TIA/minor stroke patients who
underwent surgery in the hyperacute period after onset of symp-
toms and none have looked speciﬁcally at characteristics associated
with recurrent symptoms, making direct comparison with other
studies difﬁcult. These data do suggest, however, that in larger
cohorts of patients, it may be possible to develop a scoring system
(similar in principle to ABCD227) for triaging patients based on TCD
and computerised ultrasonographic features. If this were possible,
it would enable surgeons to identify a cohort of ‘ultra’ high risk
patients who merited emergency CEA (i.e. <24 h), while others
might be allowed to wait 48e72 h for expedited surgery.
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